期刊文献+

六西格玛在凝血项目质量控制方面的应用及改进 被引量:2

Application and improvement of six sigma in quality control of coagulation analytes
下载PDF
导出
摘要 目的探讨六西格玛(6σ)在评价凝血项目分析性能上的应用价值。方法收集本实验室凝血项目的2018年国家卫健委临检中心室间质评数据和2018年6—12月的室内质控数据,选用3个不同来源的允许总误差作为本研究质量目标,分别计算各项目的σ水平。同时绘制标准化的西格玛性能验证图,结合具有批长度的Westgard西格玛规则指导制定个性化的质控策略,并计算σ<6的项目的质量目标指数(quality target index,QGI),确定质量改进方案。结果依据国家卫生行业标准,凝血酶原时间(PT)(σ=6.04)分析性能为“世界一流”水平,选择13s规则(N=2)和批长度为1000个患者样本作为质控方案;活化部分凝血活酶时间(APTT)(σ=5.08)和纤维蛋白原(FIB)(σ=5.21)的分析性能达到“优秀”水平,选择13s/22s/R4s(N=2)规则和批长度为450个患者样本作为质控方案;凝血酶时间(TT)(σ=4.60)的分析性能亦达到“良好”等级,选择13s/22s/R4s/41s(N=4)规则和批长度为200个患者样本作为质控方案。依据国家卫生行业标准,APTT需要优先改进精密度,TT和FIB则需要同时改进精密度和正确度。结论6σ能够客观评价实验室指标的分析性能,并指导实验室制定合理质控策略和质量改进方案,进一步提高实验室的检测能力。 Objective To investigate the application of six sigma in evaluating the analytical performance of coagulation analytes.Methods The data of external quality assessment(EQA)from 2018 and the data of internal quality control(IQC)from June to December 2018 were collected.Three different allowable total error(TEa)were selected as quality goals to calculate sigma value of each analyte respectively.Meanwhile,draw a standardized Sigma performance verification chart,combined with Westgard Sigma rules with batch length to guide the development of personalized quality control stategies,and the quality goal index(QGI)of coagulation analytes(sigma<6)were calculated to determine quality improvement plan.Results According to National Health Industry Standards,the analytical performance of prothrombin time(PT)(sigma=6.04)was"world-class"level,and 13s rule(N=2)with batch length of 1000 patient samples were selected as quality control schemes.The analytical performance of activated partial thromboplastin time(APTT)(sigma=5.08)and fibrinogen(FIB)(sigma=5.21)reached"excellent"level,multiple rule of 13s/22s/R4s(N=2)with batch length of 450 patient samples were selected as quality control schemes.The analytical performance thrombin time(TT)(sigma=4.60)also achieved a"good"level,so multiple rule of 13s/22s/R4s/41s(N=4)with batch length of 200 patient samples were selected as quality control schemes.According to National Health Industry Standards,the precision of APTT needs to be improved firstly,the precision and accuracy of TT and FIB need to be improved at the same time.Conclusions Six sigma can objectively evaluate the analytical performance of laboratory indicators,and guide the laboratory to develop reasonable quality control strategies and quality improvement programs,so as to further improve the laboratory detection capabilities.
作者 刘倩 杨伏猛 姚丽 李艳 付梅 徐承来 梁伟 Liu Qian;Yang Fumeng;Yao Li;Li Yan;Fu Mei;Xu Chenglai;Liang Wei(Department of Clinical Laboratory,The Second People's Hospital of Lianyungang,Lianyungang 226001,China)
出处 《国际医药卫生导报》 2020年第13期1854-1857,共4页 International Medicine and Health Guidance News
基金 江苏省连云港市卫生科研计划项目(201817) 南京医科大学康达学院科研发展基金重点项目(KD2019KYJJZD010)。
关键词 六西格玛 质量目标指数 质量控制 凝血项目 Six sigma Quality goal index(QGI) Quality control Coagulation analyte
  • 相关文献

参考文献4

二级参考文献16

  • 1LASKY FD, BOSER RB. Designing in quality through design control: a manufacturer's perspective [ J ]. Clin Chem, 1997,43 (5) : 866-872.
  • 2STANKOVIC AK, ROMEO P. The role of in vitro diagnostic companies in reducing laboratory error [J]. Clin Chem Lab Med, 2007,45(6) :781-788.
  • 3GRAS JM, PHILIPPE M. Application of the six sigma concept in clinical laboratories : a review [ J ].Clin Chem Lab Med, 2007,45 (6) :789-796.
  • 4LLOPIS MA, TRUJILLO G, LLOVET MI, et al. Quality indicators and specifications for key analytical-extranalytical processes in the clinical laboratory. Five years' experience using the six sigma concept [ J ]. Clin Chem Lab Med, 2011,49 ( 3 ) :463- 470.
  • 5KINNS H, PITKIN S, HOUSLEY D, et al . Internal quality control: best practice [ J ]. J Clin Pathol, 2013,66(12) : 1027-1032.
  • 6中华人民共和国卫生部.WS/T403-2012临床生物化学检验常规项目分析质量指标[S].北京:中国标准出版社,2013.
  • 7FRASER CG, PETERSEN PH, RICOS C, et al. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry[ J ]. Eur J Clin Chem Clin Biochem, 1992, 30(5) :311-317.
  • 8RICOS C, ALVAREZ V, CAVA F, et al. Current databases on biological variation: pros, cons and progress [ J]. Scand J Clin Lab Invest, 1999,59 (7) : 491-500.
  • 9GRAS JM, GOFFINET P, BORMANS F. Practical internal QC protocol based on six sigma and biological variation in a routine clinical chemistry laboratory [ J ]. Clin Chem ,2009,55 (Suppl) : A32.
  • 10FRIEDECKY B, KRATOCHVILA J, BUDINA M. Why do different EQA schemes have apparently different limits of acceptability [ J ]. Clin Chem Lab Med,2011,49(4) :743-745.

共引文献54

同被引文献22

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部